1,309
Views
73
CrossRef citations to date
0
Altmetric
Mini Review

Ocular Fungal Infections

&
Pages 179-189 | Received 29 Jun 2010, Accepted 10 Oct 2010, Published online: 15 Dec 2010

REFERENCES

  • Klotz SA, Penn CC, Negvesky GJ, et al. Fungal and parasitic infections of the eye. Clin Microbiol Rev. 2000;13:662–685.
  • Thomas PA. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev. 2003;16:730–797.
  • Shah CP, McKey J, Spirn MJ, et al.Ocular candidiasis: A review. Br J Ophthalmol. 2008;92:466–468.
  • Lamaris GA, Esmaeli B, Chamilos G, et al. Fungal endophthalmitis in a tertiary care cancer center: A review of 23 cases. Eur J Clin Microbiol Infect Dis. 2008;27:343–347.
  • Smith SR, Kroll AJ, Lou PL, et al. Endogenous bacterial and fungal endophthalmitis. Int Ophthalmol Clin. 2007;47:173–183.
  • Behlau I, Baker AS. Fungal infections and the eye. In: Albert DM, Jakobiec FA, Azar DT, Gragoudas ES (Eds.). Principles and Practice in Opthalmology, 2nd ed. Philadelphia: Saunders, 1999; Vol 5.
  • Valluri S, Moorthy RS. Fungal endophthalmitis: Candidiasis, aspergillosis and coccidioidomycosis. In: Yanoff M, Duker JS (Eds.). Ophthalmology, 3rd ed. Mosby, Elsevier, China. 2009; pp. 824–827.
  • Ozdek S, Urgancioglu B, Ozturk S. Recurrent endogenous Candida. Ann Ophthalmol (Skokie). 2009;41:118–120.
  • Lemley CA, Han DP. Endophthalmitis. A review of current evaluation and management. Retina. 2007;27:662–680.
  • Wong VKW, Tasman W, Eagle RCJ, et al. Bilateral Candida parapsilosis endophthalmitis. Arch Ophthalmol. 1997;115:670–672.
  • Stern WH, Tamura E, Jacobs RA, et al. Epidemic postsurgical Candida parapsilosis endophthalmitis. Ophthalmology. 1985;92:1701–1709.
  • Srdic N, Radulovic S, Nonkovic Z, et al. Two cases of exogenous endophthalmitis due to Fusarium moniliforme and Pseudomonas species as associated aetiological agents. Mycoses. 1993;36:441–444.
  • Rosenberg KD, Flynn HW Jr, Alfonso EC, et al. Fusarium endophthalmitis following keratitis associated with contact lenses. Ophthalmic Surg Lasers Imaging. 2006;37:310–313.
  • Pflugfelder SC, Flynn HW Jr, Zwickey TA, et al. Exogenous fungal endophthalmitis. Ophthalmology. 1988;95:19–30.
  • Wykoff CC, Flynn HW Jr, Miller D, et al. Exogenous fungal endophthalmitis: Microbiology and clinical outcomes. Ophthalmology. 2008;115:1501–1507.
  • Shukla PK, Kumar M, Keshava GB. Mycotic keratitis: An overview of diagnosis and therapy. Mycoses. 2008;51:183–199.
  • Saracli MA, Erdem U, Gonlum A, et al. Scedosporium apiospermum keratitis treated with itraconazole. Med Mycol. 2003;41:111–114.
  • McLeod SD. Fungal keratitis. In: Yanoff M, Duker JS (Eds.). Ophthalmology, 3rd ed. Mosby, Elsevier, China. 2009; pp. 271–273.
  • Chew HF, Jungkind DL, Mah DY, et al. Post-traumatic fungal keratitis caused by Carpoligna sp. Cornea. 2010;29:449–452.
  • Thomas PA. Mycotic keratitis: An underestimated mycosis. J Med Vet Mycol. 1994;32:235–254.
  • Hu S, Fan VC, Koonapareddy C, et al. Contact lens-related Fusarium infection: Case series experience in New York City and review of fungal keratitis. Eye Contact Lens. 2007;33:322–328.
  • Bharathi MJ, Ramakrishnan R, Meenakshi R, et al. Microbial keratitis in South India: Influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol. 2007;14:61–69.
  • Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol. 2004;15:321–327.
  • Ahearn DG, Zhang S, Stulting RD, et al. Fusarium keratitis and contact lens wear: Facts and speculations. Med Mycol. 2008;46:397–410.
  • Levin LA, Avery R, Shore JW, et al. The spectrum of orbital aspergillosis: A clinicopathological review. Survey Ophthalmol. 1996;41:142–154.
  • Fairley C, Sullivan TJ, Bartley P, et al. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. Ophthalmology. 2000;107:555–558.
  • Javey G, Zuravleff JJ, Lu VL. Fungal infections of the eye. In: Anaisie EJ, McGinnis MR, Pfaller MA (Eds.). Clinical Mycology, 2nd ed. China: Elsevier Inc., 2009; pp. 623–641.
  • Najmi NG, Song HF, Ober RR. Presumed Candida endogenous fungal endophthalmitis: A case report and literature review. Optometry. 2007;78:454–459.
  • Holland G. Endogenous fungal infection of the retina and choroid. In: Ryan SJ (Ed.). Retina, 4th ed. St. Louis: Mosby, 2005; pp. 1683–1698.
  • Khan FA, Slain D, Khakoo RA. Candida endophthalmitis: Focus on current and future antifungal treatment options. Pharmacotherapy. 2007;27:1711–1721.
  • Breit SM, Hariprasad SM, Mieler WF, et al. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol. 2005;139:135–140.
  • Deren YT, Ozdek S, Kalkanci A, et al. Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits. Can J Microbiol. 2010;56:1–7.
  • Wong VKW, Tasman W, Eagle RCJ, et al. Bilateral Candida parapsilosis endophthalmitis. Arch Ophthalmol. 1997;115:670–672.
  • Stern WH, Tamura E, Jacobs RA, et al. Epidemic postsurgical Candida parapsilosis endophthalmitis. Ophthalmology. 1985;92:1701–1709.
  • Srdic N, Radulovic S, Nonkovic Z, et al. Two cases of exogenous endophthalmitis due to Fusarium moniliforme and Pseudomonas species as associated aetiological agents. Mycoses. 1993;36:441–444.
  • Rosenberg KD, Flynn HW Jr, Alfonso EC, et al. Fusarium endophthalmitis following keratitis associated with contact lenses. Ophthalmic Surg Lasers Imaging. 2006;37:310–313.
  • Savir H, Henig E, Lehrer N. Exogenous mycotic infections of the eye and adnexia. Ann Ophthalmol. 1978;10:1013–1018.
  • Jones BR, Richards AB, Morgan G. Direct fungal infection of the eye in Britain. Trans Ophthalmol Soc UK. 1970;89:727–741.
  • Gregori NZ, Flynn HW Jr, Miller D, et al. Clinical features, management strategies, and visual acuity outcomes of Candida endophthalmitis following cataract surgery. Ophthalmic Surg Lasers Imaging. 2007;38:378–385.
  • Callanan D, Scott IU, Murray TG, et al. Early onset endophthalmitis caused by Aspergillus species following cataract surgery. Am J Ophthalmol. 2006;142:509–511.
  • Pflugfelder SC, Flynn HW Jr, Zwickey TA, et al. Exogenous fungal endophthalmitis. Ophthalmology. 1988;95:19–30.
  • Wykoff CC, Flynn HW Jr, Miller D, et al. Exogenous fungal endophthalmitis: Microbiology and clinical outcomes. Ophthalmology. 2008;115:1501–1507.
  • Yilmaz S, Ozturk I, Maden A. Microbial keratitis in West Anatolia, Turkey: A retrospective review. Int Ophthalmol. 2007;27:261–268.
  • Hu S, Fan VC, Koonapareddy C, et al. Contact lens-related Fusarium infection: Case series experience in New York City and review of fungal keratitis. Eye Contact Lens. 2007;33:322–328.
  • Lalitha P, Prajna NV, Kabra A, et al. Risk factors for treatment outcome in fungal keratitis. Ophthalmology. 2006;113:526–530.
  • Yao YF, Zhang YM, Zhou P, et al. Therapeutic penetrating keratoplasty in severe fungal keratitis using cryopreserved donor corneas. Br J Ophthalmol. 2003;87:543–547.
  • Smith AT, Spencer JT. Orbital complications resulting from lesions of the sinuses. Ann Otol Rhinol Laryngol. 1948;57:5.
  • Chandler JR, Langenbrunner DJ, Stevens ER. Pathogenesis of orbital complications in acute sinusitis. Laryngoscope. 1970;80:1414–1428.
  • Westfall CT, Baker AS, Shore JW. Infectious processes of the orbit. In: Albert DM, Jakobiec FA, Azar DT, Gragoudas ES (Eds.). Principles and Practice in Opthalmology, 2nd ed. Philadelphia: Saunders, 1999; Vol. 3, pp. 1946–1949.
  • Jeevanan J, Gendeh BS, Faridah HA, et al. Rhino-orbito-cerebral mucormycosis: A treatment dilemma. Med J Malaysia. 2006;61:106–108.
  • Murray PR, Rosenthal KS, Pfaller MA. Laboratory diagnosis of fungal diseases. In: Medical Microbiology, 6th ed. Philadelphia: Mosby, Elsevier, 2009; pp. 689–699.
  • Winn Jr, W, Allen S, Janda W, et al. Laboratory approach to the presumptive identification of fungal isolates. In: Koneman’s Color Atlas and Textbook of Diagnostic Microbiology, 6th ed. Baltimore: Lippincott Williams & Wilkins, 2006; pp. 1166–1237.
  • Forbes BA, Sahm DF, Weissfeld AS. Laboratory methods in basic mycology. In: Bailey & Scott’s Diagnostic Microbiology, 12th ed. St. Louis, Missouri: Mosby, Elsevier, 2007; pp. 629–716.
  • Willinger B. Laboratory diagnosis and therapy of invasive fungal infections. Current Drug Targets. 2006;7:513–522.
  • Arikan S. Current status of antifungal susceptibility testing methods. Med Mycol. 2007;45:569–587.
  • de Hoog GS, Guarro J, Gene J, et al. Atlas of Clinical Fungi, 2nd ed. Utrecht: Centraalbureau voor Schimmelcultures, 2000.
  • Alexander BD. Diagnosis of fungal infection: New technologies. Transplant Infect Dis. 2002;4:32–37.
  • Lau A, Chen S, Sleiman S, et al. Current status and future perspectives on molecular and serological methods in diagnostic mycology. Future Microbiol. 2009;4:1185–1222.
  • Van Gelder RN. Applications of the polymerase chain reaction to diagnosis of ophthalmic disease. Surv Ophthalmol. 2001;46:248–258.
  • Oechsler RA, Feilneier MR, Ledee DR, et al. Utility of molecular sequence analysis of the ITS rRNA region for identification of Fusarium spp. from ocular sources. Invest Ophthalmol Vis Sci. 2009;50:2230–2236.
  • Pinna A, Usai D, Sechi LA, et al. An outbreak of post-cataract surgery endophthalmitis caused by Pseudomonas aeruginosa. Ophthalmology. 2009;116:2321–2326.
  • Bubu K, Murthy KR. Combined fungal and Acanthamoeba keratitis: Diagnosis by in vivo confocal microscopy. Eye. 2007;21:271–272.
  • Erie JC, McLaren JW, Patel SV. Confocal microscopy in ophthalmology. Am J Ophthalmol. 2009;148:639–646.
  • Avunduk AM, Beuerman RW, Varnell ED, et al. Confocal microscopy of Aspergillus fumigatus keratitis. Br J Ophthalmol. 2003;87:409–910.
  • Hu J, Wang Y, Xie L. Potential role of macrophages in experimental keratomycosis. Invest Ophthalmol Vis Sci. 2009;50:2087–2094.
  • Ma L, Xie L, Dong X, et al. Role of extracellular phospholipase B of Candida albicans as a virulent factor in experimental keratomycosis. Curr Eye Res. 2009;34:761–768.
  • Yuan X, Wilhelmus KR. Toll-like receptors involved in the pathogenesis of experimental Candida albicans keratitis. Invest Ophthalmol Vis Sci. 2010;51:2094–2100.
  • Yuan X, Wilhelmus KR, Matoba AY, et al. Pathogenesis and outcome of Paecilomyces keratitis. Am J Ophthalmol. 2009;147:691–696.
  • Wu TG, Wilhelmus KR, Mitchell BM. Experimental keratomycosis in a mouse model. Invest Ophthalmol Vis Sci. 2003;44:210–216.
  • Mitchell BM, Wu TG, Chong EM, et al. Expression of matrix metalloproteinases 2 and 9 in experimental corneal injury and fungal keratitis. Cornea. 2007;26:589–593.
  • Wu TG, Keasler VV, Mitchell BM, et al. Immunosuppression affects the severity of experimental Fusarium solani keratitis. J Infect Dis. 2004;190:192–198.
  • Zhong W, Yin H, Xie L. Expression and potential role of major inflammatory cytokines in experimental keratomycosis. Mol Vis. 2009;15:1303–1311.
  • Yuan X, Hua X, Wilhelmus KR. Proinflammatory chemokines during Candida albicans keratitis. Exp Eye Res. 2010;90:413–419.
  • Sun Y, Chandra J, Mukherjee P, et al. A murine model of contact lens-associated Fusarium keratitis. Invest Ophthalmol Vis Sci. 2010; 1:1511–1516.
  • Velpandian T, Narayanan K, Nag TC, et al. Retinal toxicity of intravitreally injected plain and liposome formulation of fluconazole in rabbit eye. Indian J Ophthalmol. 2006;54:237–240.
  • Goldblum D, Frueh BE, Sarra GM, et al. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model. Antimicrob Agents Chemother. 2005;49:1359–1363.
  • Schreiber W, Olbrisch A, Vorwerk CK, et al. Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis. Invest Ophthalmol Vis Sci. 2003;44:2634–2643.
  • Ozturk F, Yavas GF, Kusbeci T, et al. Efficacy of topical caspofungin in experimental Fusarium keratitis. Cornea. 2007;26:726–728.
  • Mc Guire TW, Bullock JD, Bullock Jr JD, et al. Fungal endophthalmitis: An experimental study with a review of 17 human ocular cases. Arch Ophthalmol. 1991;109:1289–1296.
  • Kocak N, Kaynak S, Kirdar S, et al. Comparison of different antifungal treatment regimens for experimental Candida endophthalmitis in rabbit models. Mikrobiyol Bul. 2009;43:619–626.
  • Ren M, Wu X. Evaluation of three different methods to establish animal models of Acanthamoeba keratitis. Yonsei Med J. 2010;51:121–127.
  • He YG, McCulley JP, Alizadeh H, et al. A pig model of Acanthamoeba keratitis: Transmission via contaminated contact lenses. Invest Ophthalmol Vis Sci. 1992;33:126–133.
  • Gola S, Arana DM, Alonso-Monge R, et al. In vitro models to analyse fungal infection. In: New Insights in Medical Mycology, 1st ed. Netherlads: Springer, 2009; pp. 19–44.
  • Leonardi A, Curnow SJ,Zhan H, et al. Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin Exp Allergy. 2006;36:777–784.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.